Legal Matters In Risperdal You Should Know
Johnson & Johnson in conjunction with its subsidiary, Janssen Pharmaceuticals have been blamed and asked to pay for the punitive damages following complaints of gynecomastia or male breast growth allegedly caused by Risperdal. Risperidone is marketed and sold under the trade name Risperdal and is an antipsychotic drug which is designed to treat bipolar disorder, schizophrenia and symptoms of autism. The drug received its approval from the FDA in 1994, and reached a huge popularity amongst both the physicians and the patients. But the victims found plenty of complications with the drug. The defendants are facing allegations of not letting the medical community and its patients know about the possible links between Risperdal and gynecomastia. At least 13,000 product liability claims regarding Risperdal have been filed in courts all throughout the country. Presently, there are about 2,000 pending Risperdal mass tort cases in the Philadelphia Court of Common Pleas. The R...